Changed Risks for OVID THERAPEUTICS INC (OVID)

Here are risks that changed year over year. risks from the recent filings of OVID THERAPEUTICS INC. Our algorithms work hard to highlight risks unique to this company.

Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited

al trials are not necessarily predictive of future results, our drug candidates may not have favorable results in planned or future preclinical studies or clinical trials, or may not receive regulatory approval

If we are not successful in discovering, developing and commercializing additional drug candidates, our ability to expand our business and achieve our strategic objectives would be impaired

to offset future taxable income may be subject to limitation